Endocrine disruptors effect on inflammatory heart disease

内分泌干​​扰物对炎症性心脏病的影响

基本信息

  • 批准号:
    9268276
  • 负责人:
  • 金额:
    $ 16.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-01 至 2018-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long term goal of this project is to determine the effect of endocrine disruptors (EDs), beginning with bisphenol A (BPA), on auto/inflammatory cardiovascular diseases (iCVDs). Myocarditis is an autoimmune iCVD that leads to dilated cardiomyopathy (DCM) and heart failure (HF) and was listed in a recent Lancet report as the 32nd cause of death globally. Autoinflammatory CVDs including myocarditis, DCM, and atherosclerosis occur predominantly in men, who are at an increased risk of developing DCM and HF. The investigators have previously published that testosterone drives myocarditis by increasing mast cells and by activating the inflammasome (i.e. TLR4, caspase-1 and interleukin (IL)-1), resulting in cardiac remodeling, fibrosis and progression to DCM. In contrast, estrogen (E2) decreases myocarditis in female mice by elevating anti- inflammatory immune responses including IL-4/Th2 and regulatory T cells (Treg). Clinical and experimental studies indicate that E2, via the estrogen receptor (ER), mediates cardio-protection against iCVDs in females, while ER signaling has the opposite effect. Since myocarditis and DCM are strongly influenced by sex hormones, ED exposure in utero or as an adult could influence adult autoimmune CVD. To our knowledge no one has examined the potential effect of EDs on myocarditis or DCM. In preliminary studies presented here, the investigators found that a high human relevant exposure of 25 g/L of BPA administered to adult female mice in drinking water significantly increased myocarditis and converted females to a male-like inflammatory profile. ER was significantly decreased in the heart during myocarditis (using qRT-PCR of the whole heart) at this dose of BPA, while ER was significantly increased compared to controls, indicating BPA disregulation of ER signaling in the heart. Based on these findings and the literature on the cardioprotective role of ER, the investigators hypothesize that BPA increases myocarditis in female mice via ER on mast cells. The investigators will investigate the mechanisms of BPA effects on myocarditis and DCM by determining in Aim 1 whether adult exposure to BPA is acting through ER (or other ERs) to increase myocarditis in adult male and female mice, and in Aim 2 by examining the effect of prenatal exposure to BPA on adult disease in male and female offspring (F1). If BPA is activating mast cells to increase iCVD, this study will have a great impact on the understanding of disease pathogenesis.
描述(由申请人提供):该项目的长期目标是确定内分泌干扰物(EDs),从双酚A (BPA)开始,对自身/炎症性心血管疾病(icvd)的影响。心肌炎是一种自身免疫性心血管疾病,可导致扩张型心肌病(DCM)和心力衰竭(HF),在最近的《柳叶刀》报告中被列为全球第32大死因。自身炎症性心血管疾病包括心肌炎、DCM和动脉粥样硬化主要发生在男性中,他们发生DCM和HF的风险增加。研究人员先前发表的研究表明,睾酮通过增加肥大细胞和激活炎性体(即TLR4、caspase-1和白细胞介素(IL)-1)来驱动心肌炎,导致心脏重塑、纤维化和进展为DCM。相反,雌激素(E2)通过提高抗炎免疫反应(包括IL-4/Th2和调节性T细胞(Treg))来减少雌性小鼠的心肌炎。临床和实验研究表明,E2通过雌激素受体(ER)介导女性对icvd的心脏保护,而ER信号则具有相反的作用。由于心肌炎和DCM受性激素的强烈影响,子宫内或成人暴露于ED可能影响成人自身免疫性CVD。据我们所知,还没有人研究过ed对心肌炎或DCM的潜在影响。在这里提出的初步研究中,研究人员发现,成年雌性小鼠在饮用水中暴露于25 g/L的高剂量BPA,会显著增加心肌炎,并将雌性小鼠转化为雄性小鼠。在该剂量的BPA下,心肌炎期间心脏ER显著降低(使用全心脏qRT-PCR),而与对照组相比,ER显著增加,表明BPA失调心脏ER信号。基于这些发现和关于内质网心脏保护作用的文献,研究人员假设BPA通过内质网作用于肥大细胞而增加雌性小鼠的心肌炎。研究人员将研究BPA对心肌炎和DCM的影响机制,在第1阶段确定成年暴露于BPA是否通过内质网(或其他内质网)增加成年雄性和雌性小鼠的心肌炎,在第2阶段研究产前暴露于BPA对雄性和雌性后代成年疾病的影响(F1)。如果BPA是激活肥大细胞增加iCVD,这项研究将对疾病发病机制的认识产生重大影响。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sucrose-based cryoprotective storage of extracellular vesicles.
  • DOI:
    10.1016/j.vesic.2022.100016
  • 发表时间:
    2022-12
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sierra A. Walker;Irina Davidovich;Yubo Yang;A. Lai;J. P. Goncalves;Vatsal Deliwala;S. Busatto;Shane Shapiro;Na'ama Koifman;C. Salomon;Y. Talmon;Joy Wolfram
  • 通讯作者:
    Sierra A. Walker;Irina Davidovich;Yubo Yang;A. Lai;J. P. Goncalves;Vatsal Deliwala;S. Busatto;Shane Shapiro;Na'ama Koifman;C. Salomon;Y. Talmon;Joy Wolfram
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DeLisa Fairweather其他文献

DeLisa Fairweather的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DeLisa Fairweather', 18)}}的其他基金

Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex
线粒体细胞外囊泡在不同性别的 CVB3 心肌炎中的作用
  • 批准号:
    10644008
  • 财政年份:
    2022
  • 资助金额:
    $ 16.58万
  • 项目类别:
Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex
线粒体细胞外囊泡在不同性别的 CVB3 心肌炎中的作用
  • 批准号:
    10852725
  • 财政年份:
    2022
  • 资助金额:
    $ 16.58万
  • 项目类别:
Sex differences in exercise-induced mitochondrial function during viral myocarditis
病毒性心肌炎期间运动诱发的线粒体功能的性别差异
  • 批准号:
    10227233
  • 财政年份:
    2020
  • 资助金额:
    $ 16.58万
  • 项目类别:
Adipose-derived biogenic nanoparticles for treatment of myocarditis/DCM(MPDPI)
脂肪源性生物纳米颗粒治疗心肌炎/扩张型心肌病(MPDPI)
  • 批准号:
    10089412
  • 财政年份:
    2020
  • 资助金额:
    $ 16.58万
  • 项目类别:
Role of viral mitophagosomes in driving sex differences in myocarditis
病毒线粒体吞噬体在心肌炎性别差异中的作用
  • 批准号:
    9764769
  • 财政年份:
    2019
  • 资助金额:
    $ 16.58万
  • 项目类别:
Role of viral mitophagosomes in driving sex differences in myocarditis
病毒线粒体吞噬体在心肌炎性别差异中的作用
  • 批准号:
    9892954
  • 财政年份:
    2019
  • 资助金额:
    $ 16.58万
  • 项目类别:
Endocrine disruptors effect on inflammatory heart disease
内分泌干​​扰物对炎症性心脏病的影响
  • 批准号:
    8765093
  • 财政年份:
    2014
  • 资助金额:
    $ 16.58万
  • 项目类别:
Sex Differences in Complement during Myocarditis/DCM
心肌炎/扩张型心肌病期间补体的性别差异
  • 批准号:
    8370119
  • 财政年份:
    2012
  • 资助金额:
    $ 16.58万
  • 项目类别:
Sex Differences in Complement during Myocarditis/DCM
心肌炎/扩张型心肌病期间补体的性别差异
  • 批准号:
    9270289
  • 财政年份:
    2012
  • 资助金额:
    $ 16.58万
  • 项目类别:
Sex Differences in Complement during Myocarditis/DCM
心肌炎/扩张型心肌病期间补体的性别差异
  • 批准号:
    8896850
  • 财政年份:
    2012
  • 资助金额:
    $ 16.58万
  • 项目类别:

相似海外基金

Endocrine Disrupting Chemicals and Male-biased Neurobehavioral Disorders
内分泌干​​扰化学物质和男性神经行为障碍
  • 批准号:
    10561338
  • 财政年份:
    2023
  • 资助金额:
    $ 16.58万
  • 项目类别:
Pesticide exposures, mental health and endocrine disruption among children growing up near pesticide spray sites.
在农药喷洒点附近长大的儿童的农药接触、心理健康和内分泌紊乱。
  • 批准号:
    10482338
  • 财政年份:
    2020
  • 资助金额:
    $ 16.58万
  • 项目类别:
The revelation of the mechanism of the post-fertilization effect of paternal exposure on endocrine disruptors on the development and fertilizing capacity of the male offspring.
揭示父本暴露内分泌干扰物的受精后效应对雄性子代发育和受精能力的影响机制。
  • 批准号:
    20K18092
  • 财政年份:
    2020
  • 资助金额:
    $ 16.58万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanisms of atrazine endocrine disruption
阿特拉津内分泌干扰机制
  • 批准号:
    9895294
  • 财政年份:
    2020
  • 资助金额:
    $ 16.58万
  • 项目类别:
Pesticide exposures, mental health and endocrine disruption among children growing up near pesticide spray sites.
在农药喷洒点附近长大的儿童的农药接触、心理健康和内分泌紊乱。
  • 批准号:
    10267166
  • 财政年份:
    2020
  • 资助金额:
    $ 16.58万
  • 项目类别:
Endocrine Disruptors and Heart Health
内分泌干​​扰物与心脏健康
  • 批准号:
    10330458
  • 财政年份:
    2018
  • 资助金额:
    $ 16.58万
  • 项目类别:
Endocrine Disruptors and Heart Health
内分泌干​​扰物与心脏健康
  • 批准号:
    10089445
  • 财政年份:
    2018
  • 资助金额:
    $ 16.58万
  • 项目类别:
Endocrine Disruptors and Heart Health
内分泌干​​扰物与心脏健康
  • 批准号:
    10550014
  • 财政年份:
    2018
  • 资助金额:
    $ 16.58万
  • 项目类别:
Endocrine Disruptors and Heart Health
内分泌干​​扰物与心脏健康
  • 批准号:
    10251514
  • 财政年份:
    2018
  • 资助金额:
    $ 16.58万
  • 项目类别:
Addiction, Gender and Endocrine Disruptors
成瘾、性别和内分泌干扰物
  • 批准号:
    9333775
  • 财政年份:
    2017
  • 资助金额:
    $ 16.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了